Nexavar Indications/Uses

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Hepatocellular Carcinoma (HCC): Nexavar is indicated for the treatment of hepatocellular carcinoma (see Pharmacology: Pharmacodynamics under Actions).
Renal Cell Carcinoma (RCC): Nexavar is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-α or interleukin-2 based therapy or are considered unsuitable for such therapy.
Differentiated Thyroid Carcinoma (DTC): Nexavar is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.

sorafenib

Manufacturer:

Bayer

Distributor:

Zuellig

Firma Chun Cheong